Verinetics’ primary product is a take-home box that controls the distribution of methadone, a common treatment for opioid use disorder. The startup will present its technology at CED’s Venture Connect summit in Raleigh on March 20-21.
Read More
As it marks a transition from having been focused on product development to delivering and supporting product in customer hands, Verinetics, Inc. (Verinetics) announces changes to its management structure that are intended to reflect the company’s recent successes and the growth trajectory.
Read More
Verinetics Collaboration with VA Greenhouse Initiative Featured in The VAntage
Read More
“In developing DSv1, Verinetics’ mission includes building trust between these individuals and their health care providers”
Read More
“Verinetics Awarded $1.5M Phase II SBIR Contract from the National Institute on Drug Abuse”
Read More
“DSv1 is being developed as an alternative solution that increases access to take home methadone privileges”
Read More